ESOP21 May 2026, 06:41 pm
Windlas Biotech Grants Stock Options Under ESOS 2023 & Windlas Plan 2025
AI Summary
Windlas Biotech Ltd has announced the grant of stock options/units to eligible employees under the 'WBL Employee Stock Option Scheme 2023' (ESOS 2023) and 'Windlas Plan 2025'. The Nomination and Remuneration Committee approved the grant of 21,250 stock options/units under the Plan and 15,750 stock options under ESOS 2023 on May 21, 2026. The exercise price for ESOS 2023 options will be determined by the committee, with a discount of up to 25% from the market price. Units under Windlas Plan 2025 will be granted at face value of ₹5 per share.
Key Highlights
- Windlas Biotech grants 15,750 options under ESOS 2023 to eligible employees.
- 21,250 stock options/units granted under Windlas Plan 2025.
- ESOS 2023 options vest between 1 to 4 years from the grant date.
- Windlas Plan 2025 units vest in four equal installments over 4 years.
- Exercise period for vested options/units is four years from vesting date.
Price Impact
More from WINDLAS*